The expression of EP4, a PGE2 receptor, in T-cell acute lymphoblastic leukemia samples leads to an increase in intracellular cAMP levels, which sensitizes T-ALL to dexamethasone. Here, PTGER4 is linked to acute lymphoblastic leukemia.